Rank | Gene Set | Z-score |
---|---|---|
1 | immunoglobulin mediated immune response (GO:0016064) | 4.50946794 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.43788919 |
3 | aromatic amino acid family catabolic process (GO:0009074) | 4.28332751 |
4 | tryptophan catabolic process (GO:0006569) | 4.27545962 |
5 | indole-containing compound catabolic process (GO:0042436) | 4.27545962 |
6 | indolalkylamine catabolic process (GO:0046218) | 4.27545962 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.23106348 |
8 | L-phenylalanine catabolic process (GO:0006559) | 4.23106348 |
9 | complement activation, alternative pathway (GO:0006957) | 4.21130683 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.20561402 |
11 | protein carboxylation (GO:0018214) | 4.18928343 |
12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.18928343 |
13 | response to peptidoglycan (GO:0032494) | 4.16406682 |
14 | urea cycle (GO:0000050) | 4.02175308 |
15 | urea metabolic process (GO:0019627) | 4.02175308 |
16 | L-phenylalanine metabolic process (GO:0006558) | 4.01937429 |
17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.01937429 |
18 | tryptophan metabolic process (GO:0006568) | 3.99564559 |
19 | negative regulation of interleukin-12 production (GO:0032695) | 3.97850268 |
20 | kynurenine metabolic process (GO:0070189) | 3.90208069 |
21 | detection of other organism (GO:0098543) | 3.86917355 |
22 | macrophage activation involved in immune response (GO:0002281) | 3.82304520 |
23 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.80571815 |
24 | detection of bacterium (GO:0016045) | 3.79528757 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69989571 |
26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.69559044 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68563520 |
28 | negative regulation of cell killing (GO:0031342) | 3.68563520 |
29 | nitrogen cycle metabolic process (GO:0071941) | 3.68143688 |
30 | T-helper 1 type immune response (GO:0042088) | 3.65554881 |
31 | regulation of protein activation cascade (GO:2000257) | 3.64363793 |
32 | glycosphingolipid catabolic process (GO:0046479) | 3.62467930 |
33 | bile acid biosynthetic process (GO:0006699) | 3.61800940 |
34 | phospholipid efflux (GO:0033700) | 3.58443913 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 3.57531258 |
36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.57071474 |
37 | cysteine metabolic process (GO:0006534) | 3.55625407 |
38 | myeloid dendritic cell differentiation (GO:0043011) | 3.54030474 |
39 | regulation of antigen processing and presentation (GO:0002577) | 3.51887190 |
40 | glyoxylate metabolic process (GO:0046487) | 3.50810408 |
41 | regulation of complement activation (GO:0030449) | 3.49914919 |
42 | reverse cholesterol transport (GO:0043691) | 3.49230528 |
43 | plasma lipoprotein particle clearance (GO:0034381) | 3.48200372 |
44 | cholesterol efflux (GO:0033344) | 3.46251193 |
45 | regulation of cholesterol esterification (GO:0010872) | 3.43147888 |
46 | B cell mediated immunity (GO:0019724) | 3.41794934 |
47 | negative regulation of fibrinolysis (GO:0051918) | 3.41645658 |
48 | neutrophil activation involved in immune response (GO:0002283) | 3.41598437 |
49 | * surfactant homeostasis (GO:0043129) | 3.37924112 |
50 | regulation of triglyceride catabolic process (GO:0010896) | 3.35386336 |
51 | detection of external biotic stimulus (GO:0098581) | 3.34801719 |
52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33649919 |
53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33649496 |
54 | oligosaccharide catabolic process (GO:0009313) | 3.33382538 |
55 | sulfur amino acid catabolic process (GO:0000098) | 3.30869124 |
56 | glycolipid catabolic process (GO:0019377) | 3.28958902 |
57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28692994 |
58 | regulation of macrophage chemotaxis (GO:0010758) | 3.27138028 |
59 | NIK/NF-kappaB signaling (GO:0038061) | 3.25633455 |
60 | myeloid dendritic cell activation (GO:0001773) | 3.25396029 |
61 | protein-lipid complex remodeling (GO:0034368) | 3.20455239 |
62 | macromolecular complex remodeling (GO:0034367) | 3.20455239 |
63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.20455239 |
64 | regulation of fibrinolysis (GO:0051917) | 3.19734505 |
65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19251171 |
66 | aldehyde catabolic process (GO:0046185) | 3.18687948 |
67 | germinal center formation (GO:0002467) | 3.17023956 |
68 | complement activation (GO:0006956) | 3.13880814 |
69 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13726791 |
70 | amino sugar catabolic process (GO:0046348) | 3.10793632 |
71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10098139 |
72 | detection of molecule of bacterial origin (GO:0032490) | 3.09422926 |
73 | homocysteine metabolic process (GO:0050667) | 3.09130735 |
74 | cellular extravasation (GO:0045123) | 3.08880541 |
75 | positive regulation of type 2 immune response (GO:0002830) | 3.08589856 |
76 | regulation of mononuclear cell migration (GO:0071675) | 3.07941008 |
77 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07107606 |
78 | type I interferon signaling pathway (GO:0060337) | 3.06874601 |
79 | cellular response to type I interferon (GO:0071357) | 3.06874601 |
80 | bile acid metabolic process (GO:0008206) | 3.05148121 |
81 | regulation of mast cell degranulation (GO:0043304) | 3.05063490 |
82 | response to type I interferon (GO:0034340) | 3.04989325 |
83 | complement activation, classical pathway (GO:0006958) | 3.04358273 |
84 | negative regulation of cholesterol transport (GO:0032375) | 3.02800728 |
85 | negative regulation of sterol transport (GO:0032372) | 3.02800728 |
86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01957450 |
87 | cellular response to interferon-gamma (GO:0071346) | 3.00746640 |
88 | aromatic amino acid family metabolic process (GO:0009072) | 3.00245510 |
89 | phospholipid homeostasis (GO:0055091) | 2.97925250 |
90 | low-density lipoprotein particle remodeling (GO:0034374) | 2.97425681 |
91 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.96011470 |
92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.96011470 |
93 | cellular biogenic amine catabolic process (GO:0042402) | 2.95896411 |
94 | amine catabolic process (GO:0009310) | 2.95896411 |
95 | fibrinolysis (GO:0042730) | 2.95846336 |
96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95609912 |
97 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95584027 |
98 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.95230795 |
99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.93374668 |
100 | protein activation cascade (GO:0072376) | 2.93219896 |
101 | indolalkylamine metabolic process (GO:0006586) | 2.91379156 |
102 | regulation of tolerance induction (GO:0002643) | 2.89595258 |
103 | detection of biotic stimulus (GO:0009595) | 2.88700336 |
104 | amino-acid betaine metabolic process (GO:0006577) | 2.88383083 |
105 | imidazole-containing compound metabolic process (GO:0052803) | 2.87530322 |
106 | positive regulation of mast cell activation (GO:0033005) | 2.86430156 |
107 | response to muramyl dipeptide (GO:0032495) | 2.85231789 |
108 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84401779 |
109 | B cell receptor signaling pathway (GO:0050853) | 2.84034731 |
110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.83783586 |
111 | tyrosine metabolic process (GO:0006570) | 2.82757767 |
112 | acylglycerol homeostasis (GO:0055090) | 2.82520417 |
113 | triglyceride homeostasis (GO:0070328) | 2.82520417 |
114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82136810 |
115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82136810 |
116 | modulation by symbiont of host immune response (GO:0052553) | 2.82136810 |
117 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82136810 |
118 | modulation by symbiont of host defense response (GO:0052031) | 2.82136810 |
119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82136810 |
120 | pinocytosis (GO:0006907) | 2.81962245 |
121 | response to interferon-gamma (GO:0034341) | 2.81035108 |
122 | ceramide catabolic process (GO:0046514) | 2.80921694 |
123 | acute-phase response (GO:0006953) | 2.80216042 |
124 | plasma lipoprotein particle assembly (GO:0034377) | 2.79482678 |
125 | positive regulation of blood coagulation (GO:0030194) | 2.78949656 |
126 | positive regulation of hemostasis (GO:1900048) | 2.78949656 |
127 | respiratory burst (GO:0045730) | 2.78921718 |
128 | regulation of leukocyte degranulation (GO:0043300) | 2.78545329 |
129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.77870450 |
130 | regulation of T cell tolerance induction (GO:0002664) | 2.77805203 |
131 | defense response to protozoan (GO:0042832) | 2.77400485 |
132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76858107 |
133 | positive regulation of lipid catabolic process (GO:0050996) | 2.75305198 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.74781340 |
135 | benzene-containing compound metabolic process (GO:0042537) | 2.74727588 |
136 | dendritic cell differentiation (GO:0097028) | 2.74286719 |
137 | positive regulation of coagulation (GO:0050820) | 2.73275761 |
138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72862080 |
139 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72764292 |
140 | positive regulation of interferon-alpha production (GO:0032727) | 2.72726107 |
141 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72156970 |
142 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72070808 |
143 | regulation of superoxide anion generation (GO:0032928) | 2.71802353 |
144 | cellular glucuronidation (GO:0052695) | 2.70491361 |
145 | cholesterol homeostasis (GO:0042632) | 2.70334251 |
146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70331146 |
147 | positive regulation of mast cell degranulation (GO:0043306) | 2.70331146 |
148 | bile acid and bile salt transport (GO:0015721) | 2.70145619 |
149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70076792 |
150 | regulation of cholesterol storage (GO:0010885) | 2.69895678 |
151 | sterol homeostasis (GO:0055092) | 2.69579943 |
152 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69440271 |
153 | response to protozoan (GO:0001562) | 2.69111325 |
154 | positive regulation of leukocyte degranulation (GO:0043302) | 2.68706831 |
155 | serine family amino acid catabolic process (GO:0009071) | 2.68536443 |
156 | N-acetylneuraminate metabolic process (GO:0006054) | 2.68479349 |
157 | regulation of podosome assembly (GO:0071801) | 2.68215950 |
158 | low-density lipoprotein particle clearance (GO:0034383) | 2.68165108 |
159 | urate metabolic process (GO:0046415) | 2.67820903 |
160 | myeloid cell activation involved in immune response (GO:0002275) | 2.67727636 |
161 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67285181 |
162 | lipoprotein metabolic process (GO:0042157) | 2.66786873 |
163 | protein-lipid complex assembly (GO:0065005) | 2.65252852 |
164 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65191786 |
165 | regulation of hypersensitivity (GO:0002883) | 2.65017197 |
166 | macrophage activation (GO:0042116) | 2.64695772 |
167 | positive regulation of B cell differentiation (GO:0045579) | 2.64351655 |
168 | lysine catabolic process (GO:0006554) | 2.64332426 |
169 | lysine metabolic process (GO:0006553) | 2.64332426 |
170 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63947722 |
171 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63947722 |
172 | plasma lipoprotein particle organization (GO:0071827) | 2.63692554 |
173 | cholesterol transport (GO:0030301) | 2.63233302 |
174 | sterol transport (GO:0015918) | 2.63233302 |
175 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62470357 |
176 | response to host immune response (GO:0052572) | 2.62470357 |
177 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.60556242 |
178 | T cell costimulation (GO:0031295) | 2.60367976 |
179 | * cellular response to thyroid hormone stimulus (GO:0097067) | 2.59450288 |
180 | granulocyte activation (GO:0036230) | 2.57815005 |
181 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56453291 |
182 | lymphocyte costimulation (GO:0031294) | 2.55878150 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.52465274 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89910238 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.87754612 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.29421145 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.14547711 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05803003 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95195745 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35784026 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07783120 |
10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98853190 |
11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87477573 |
12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.77767613 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.69338428 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67140488 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66512048 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63929820 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.35824266 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33743152 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32543596 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.31148689 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30453486 |
22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24118550 |
23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09488254 |
24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08224848 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02664570 |
26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.00439518 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93096066 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89721362 |
29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.88524326 |
30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84485264 |
31 | MYC_22102868_ChIP-Seq_BL_Human | 1.84049839 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77372628 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74172959 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73191374 |
35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71863057 |
36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66717785 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65572940 |
38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61946302 |
39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59790911 |
40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53969836 |
41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49328557 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49119656 |
43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46539969 |
44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44434929 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40948931 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39636733 |
47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37214413 |
48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35597686 |
49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34815115 |
50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34738281 |
51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34037189 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32869973 |
53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30710510 |
54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29576998 |
55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27668693 |
56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27353618 |
57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25117890 |
58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24518961 |
59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24478928 |
60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23779876 |
61 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22261337 |
62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22175264 |
63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21989345 |
64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20200062 |
65 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19658871 |
66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19349244 |
67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18361628 |
68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17863227 |
69 | MAF_26560356_Chip-Seq_TH2_Human | 1.17765042 |
70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17704113 |
71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16378848 |
72 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15903132 |
73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14423493 |
74 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14243196 |
75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12881341 |
76 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12128760 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11724343 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11637745 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11442027 |
80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08952525 |
81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08605584 |
82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07220192 |
83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07090691 |
84 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05545943 |
85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05480810 |
86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05480810 |
87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05319323 |
88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05306648 |
89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04884227 |
90 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04516971 |
91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02957250 |
92 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02867004 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02335191 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01818686 |
95 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01060479 |
96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00266176 |
97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99396790 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98267443 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98202489 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97588044 |
101 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94709262 |
102 | MAF_26560356_Chip-Seq_TH1_Human | 0.94340908 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94329514 |
104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93824914 |
105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93450745 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92592450 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91647448 |
108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90089397 |
109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89597899 |
110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89425858 |
111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88512105 |
112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85493209 |
113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85381952 |
114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85206775 |
115 | MYB_26560356_Chip-Seq_TH2_Human | 0.84832155 |
116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84808308 |
117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84668306 |
118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83732908 |
119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82504481 |
120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82180924 |
121 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.82124089 |
122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81954953 |
123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.81082524 |
124 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80359910 |
125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79975022 |
126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79975022 |
127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79962878 |
128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77960373 |
129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77000421 |
130 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76858429 |
131 | GATA3_26560356_Chip-Seq_TH2_Human | 0.76433652 |
132 | MYB_26560356_Chip-Seq_TH1_Human | 0.76398608 |
133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75299018 |
134 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75002819 |
135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73332443 |
136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72830797 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.59234755 |
2 | MP0005360_urolithiasis | 4.25950711 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.62543140 |
4 | MP0001835_abnormal_antigen_presentation | 3.27464048 |
5 | MP0002138_abnormal_hepatobiliary_system | 3.26738722 |
6 | MP0005365_abnormal_bile_salt | 3.10507589 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.99283174 |
8 | MP0004782_abnormal_surfactant_physiolog | 2.86808427 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86633147 |
10 | MP0009840_abnormal_foam_cell | 2.80470408 |
11 | MP0003436_decreased_susceptibility_to | 2.47539948 |
12 | MP0003252_abnormal_bile_duct | 2.43756858 |
13 | MP0005083_abnormal_biliary_tract | 2.42932614 |
14 | MP0002254_reproductive_system_inflammat | 2.24708397 |
15 | MP0000685_abnormal_immune_system | 2.24366233 |
16 | MP0005058_abnormal_lysosome_morphology | 2.17747385 |
17 | MP0010329_abnormal_lipoprotein_level | 2.14454005 |
18 | MP0009785_altered_susceptibility_to | 2.02734349 |
19 | MP0005387_immune_system_phenotype | 2.01980409 |
20 | MP0001790_abnormal_immune_system | 2.01980409 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.01889984 |
22 | MP0003724_increased_susceptibility_to | 1.94692095 |
23 | MP0002419_abnormal_innate_immunity | 1.92634484 |
24 | MP0005025_abnormal_response_to | 1.78250239 |
25 | MP0009764_decreased_sensitivity_to | 1.76016540 |
26 | MP0005332_abnormal_amino_acid | 1.74887134 |
27 | MP0006082_CNS_inflammation | 1.69241844 |
28 | MP0004019_abnormal_vitamin_homeostasis | 1.67159213 |
29 | MP0003195_calcinosis | 1.63911062 |
30 | MP0003806_abnormal_nucleotide_metabolis | 1.63669017 |
31 | MP0005000_abnormal_immune_tolerance | 1.61886482 |
32 | MP0000609_abnormal_liver_physiology | 1.59219066 |
33 | MP0001666_abnormal_nutrient_absorption | 1.56056072 |
34 | MP0003303_peritoneal_inflammation | 1.55508052 |
35 | MP0008469_abnormal_protein_level | 1.51562084 |
36 | MP0001800_abnormal_humoral_immune | 1.51006511 |
37 | MP0004510_myositis | 1.49611933 |
38 | MP0002452_abnormal_antigen_presenting | 1.49006586 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.45880457 |
40 | MP0001853_heart_inflammation | 1.43682581 |
41 | MP0005464_abnormal_platelet_physiology | 1.43338710 |
42 | MP0001958_emphysema | 1.42647821 |
43 | MP0000858_altered_metastatic_potential | 1.41987018 |
44 | MP0002118_abnormal_lipid_homeostasis | 1.37406967 |
45 | MP0002723_abnormal_immune_serum | 1.36534174 |
46 | MP0003183_abnormal_peptide_metabolism | 1.36008204 |
47 | MP0001845_abnormal_inflammatory_respons | 1.35488071 |
48 | MP0009643_abnormal_urine_homeostasis | 1.32767768 |
49 | MP0001533_abnormal_skeleton_physiology | 1.29704963 |
50 | MP0005319_abnormal_enzyme/_coenzyme | 1.29644706 |
51 | MP0005671_abnormal_response_to | 1.26621395 |
52 | MP0008260_abnormal_autophagy | 1.26319052 |
53 | MP0009278_abnormal_bone_marrow | 1.26176418 |
54 | MP0002398_abnormal_bone_marrow | 1.21802408 |
55 | MP0002405_respiratory_system_inflammati | 1.21484508 |
56 | MP0001545_abnormal_hematopoietic_system | 1.20406023 |
57 | MP0005397_hematopoietic_system_phenotyp | 1.20406023 |
58 | MP0003186_abnormal_redox_activity | 1.20273560 |
59 | MP0004947_skin_inflammation | 1.18288556 |
60 | MP0003075_altered_response_to | 1.17889733 |
61 | MP0000604_amyloidosis | 1.17338869 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.17200110 |
63 | MP0003763_abnormal_thymus_physiology | 1.16363885 |
64 | MP0010155_abnormal_intestine_physiology | 1.15906278 |
65 | MP0010368_abnormal_lymphatic_system | 1.15796555 |
66 | MP0001819_abnormal_immune_cell | 1.14012374 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13926695 |
68 | MP0003300_gastrointestinal_ulcer | 1.13083592 |
69 | MP0002420_abnormal_adaptive_immunity | 1.12044037 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.11174598 |
71 | MP0003828_pulmonary_edema | 1.10585346 |
72 | MP0005167_abnormal_blood-brain_barrier | 1.10319671 |
73 | MP0000689_abnormal_spleen_morphology | 1.10164839 |
74 | MP0004883_abnormal_blood_vessel | 1.09068860 |
75 | MP0002136_abnormal_kidney_physiology | 1.07676463 |
76 | MP0002166_altered_tumor_susceptibility | 1.05351734 |
77 | MP0000343_altered_response_to | 1.05085004 |
78 | MP0003091_abnormal_cell_migration | 1.03583447 |
79 | MP0009763_increased_sensitivity_to | 1.01996654 |
80 | MP0005166_decreased_susceptibility_to | 1.01803746 |
81 | MP0003866_abnormal_defecation | 0.99393228 |
82 | MP0002722_abnormal_immune_system | 0.98745600 |
83 | MP0003690_abnormal_glial_cell | 0.98699277 |
84 | MP0005164_abnormal_response_to | 0.97833374 |
85 | MP0003329_amyloid_beta_deposits | 0.97229502 |
86 | MP0000249_abnormal_blood_vessel | 0.96346455 |
87 | MP0001851_eye_inflammation | 0.95861590 |
88 | MP0002998_abnormal_bone_remodeling | 0.95170059 |
89 | MP0002876_abnormal_thyroid_physiology | 0.94437065 |
90 | MP0008004_abnormal_stomach_pH | 0.91964340 |
91 | MP0000598_abnormal_liver_morphology | 0.90136628 |
92 | MP0002132_abnormal_respiratory_system | 0.87510707 |
93 | MP0002295_abnormal_pulmonary_circulatio | 0.87329001 |
94 | MP0005310_abnormal_salivary_gland | 0.87202898 |
95 | MP0000920_abnormal_myelination | 0.87091212 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.84876307 |
97 | MP0005165_increased_susceptibility_to | 0.84591730 |
98 | MP0002006_tumorigenesis | 0.83479009 |
99 | MP0002933_joint_inflammation | 0.83191727 |
100 | MP0001873_stomach_inflammation | 0.82820242 |
101 | MP0005451_abnormal_body_composition | 0.82798373 |
102 | MP0001764_abnormal_homeostasis | 0.81531270 |
103 | MP0003172_abnormal_lysosome_physiology | 0.81267883 |
104 | MP0000716_abnormal_immune_system | 0.81154785 |
105 | MP0001756_abnormal_urination | 0.80684327 |
106 | MP0001879_abnormal_lymphatic_vessel | 0.80253268 |
107 | MP0003448_altered_tumor_morphology | 0.79440865 |
108 | MP0001881_abnormal_mammary_gland | 0.76901711 |
109 | MP0001663_abnormal_digestive_system | 0.76266669 |
110 | MP0002877_abnormal_melanocyte_morpholog | 0.75243949 |
111 | MP0003566_abnormal_cell_adhesion | 0.71990553 |
112 | MP0003795_abnormal_bone_structure | 0.71468564 |
113 | MP0009642_abnormal_blood_homeostasis | 0.71071961 |
114 | MP0003656_abnormal_erythrocyte_physiolo | 0.69633753 |
115 | MP0005647_abnormal_sex_gland | 0.69418137 |
116 | MP0005408_hypopigmentation | 0.68670355 |
117 | MP0001542_abnormal_bone_strength | 0.67399030 |
118 | MP0002133_abnormal_respiratory_system | 0.66129376 |
119 | MP0005388_respiratory_system_phenotype | 0.66129376 |
120 | MP0008438_abnormal_cutaneous_collagen | 0.65658784 |
121 | MP0003045_fibrosis | 0.65067374 |
122 | MP0010234_abnormal_vibrissa_follicle | 0.64943532 |
123 | MP0005390_skeleton_phenotype | 0.63605560 |
124 | MP0008874_decreased_physiological_sensi | 0.63402965 |
125 | MP0005023_abnormal_wound_healing | 0.63099159 |
126 | MP0002277_abnormal_respiratory_mucosa | 0.62949634 |
127 | MP0000767_abnormal_smooth_muscle | 0.62838152 |
128 | MP0005084_abnormal_gallbladder_morpholo | 0.62578985 |
129 | MP0002429_abnormal_blood_cell | 0.61794195 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.59024619 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.59024619 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.59024619 |
4 | Systemic lupus erythematosus (HP:0002725) | 5.10384801 |
5 | Complement deficiency (HP:0004431) | 5.01376436 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.88972668 |
7 | Deep venous thrombosis (HP:0002625) | 4.67677660 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.48554128 |
9 | Interstitial pulmonary disease (HP:0006530) | 4.34317539 |
10 | Eczematoid dermatitis (HP:0000976) | 4.33963729 |
11 | Recurrent abscess formation (HP:0002722) | 4.23640405 |
12 | Joint hemorrhage (HP:0005261) | 4.20332441 |
13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.19859390 |
14 | Glomerulonephritis (HP:0000099) | 4.08741713 |
15 | Intrahepatic cholestasis (HP:0001406) | 4.08495317 |
16 | Abnormality of complement system (HP:0005339) | 4.05766800 |
17 | Xanthomatosis (HP:0000991) | 4.03156780 |
18 | Prolonged partial thromboplastin time (HP:0003645) | 3.98741708 |
19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.98119067 |
20 | Loss of speech (HP:0002371) | 3.48910072 |
21 | Myocardial infarction (HP:0001658) | 3.46715909 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.40260961 |
23 | Abnormality of macrophages (HP:0004311) | 3.34434352 |
24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29389793 |
25 | Gastrointestinal stroma tumor (HP:0100723) | 3.22858168 |
26 | Nephritis (HP:0000123) | 3.11941634 |
27 | Hyperlipoproteinemia (HP:0010980) | 3.07002577 |
28 | Recurrent sinusitis (HP:0011108) | 3.02093500 |
29 | Recurrent skin infections (HP:0001581) | 3.00889284 |
30 | Obstructive lung disease (HP:0006536) | 3.00361832 |
31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00361832 |
32 | Hypobetalipoproteinemia (HP:0003563) | 2.99464719 |
33 | Purpura (HP:0000979) | 2.96063344 |
34 | Meningitis (HP:0001287) | 2.91227605 |
35 | Vacuolated lymphocytes (HP:0001922) | 2.89531391 |
36 | Autoimmune thrombocytopenia (HP:0001973) | 2.88209172 |
37 | Esophageal varix (HP:0002040) | 2.87249258 |
38 | Disinhibition (HP:0000734) | 2.86047880 |
39 | Gout (HP:0001997) | 2.74099853 |
40 | Pulmonary infiltrates (HP:0002113) | 2.68879731 |
41 | Neurofibrillary tangles (HP:0002185) | 2.68066720 |
42 | Epidermoid cyst (HP:0200040) | 2.66995782 |
43 | Axonal loss (HP:0003447) | 2.64793623 |
44 | Abnormality of the nasal mucosa (HP:0000433) | 2.64647437 |
45 | Cellulitis (HP:0100658) | 2.61703395 |
46 | Malnutrition (HP:0004395) | 2.58991606 |
47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.58457431 |
48 | Pustule (HP:0200039) | 2.57824117 |
49 | Restrictive lung disease (HP:0002091) | 2.56796847 |
50 | Hyperammonemia (HP:0001987) | 2.56532279 |
51 | Recurrent viral infections (HP:0004429) | 2.56529872 |
52 | Fat malabsorption (HP:0002630) | 2.56503929 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55457490 |
54 | Amyloidosis (HP:0011034) | 2.55256360 |
55 | Hypoalphalipoproteinemia (HP:0003233) | 2.54779536 |
56 | Vascular calcification (HP:0004934) | 2.54071643 |
57 | Abnormality of purine metabolism (HP:0004352) | 2.53957520 |
58 | Hypolipoproteinemia (HP:0010981) | 2.53024618 |
59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52227984 |
60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51738058 |
61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51738058 |
62 | Gingival bleeding (HP:0000225) | 2.50478143 |
63 | Tubulointerstitial fibrosis (HP:0005576) | 2.47100165 |
64 | Gingivitis (HP:0000230) | 2.45439560 |
65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45395865 |
66 | Hypercholesterolemia (HP:0003124) | 2.41366489 |
67 | Nasal polyposis (HP:0100582) | 2.41317593 |
68 | Hematochezia (HP:0002573) | 2.40293387 |
69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.40277696 |
70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38414971 |
71 | Colitis (HP:0002583) | 2.36551289 |
72 | Abnormality of proline metabolism (HP:0010907) | 2.36430786 |
73 | Hydroxyprolinuria (HP:0003080) | 2.36430786 |
74 | Increased serum ferritin (HP:0003281) | 2.35741968 |
75 | Hemoptysis (HP:0002105) | 2.35576279 |
76 | Orchitis (HP:0100796) | 2.35248582 |
77 | Recurrent bronchitis (HP:0002837) | 2.32563917 |
78 | Hyperglycinuria (HP:0003108) | 2.31764807 |
79 | Mediastinal lymphadenopathy (HP:0100721) | 2.29869852 |
80 | Hepatocellular carcinoma (HP:0001402) | 2.29468880 |
81 | Cardiovascular calcification (HP:0011915) | 2.28568130 |
82 | Osteomyelitis (HP:0002754) | 2.28558590 |
83 | Polycythemia (HP:0001901) | 2.28488505 |
84 | Recurrent fungal infections (HP:0002841) | 2.28288753 |
85 | Increased IgE level (HP:0003212) | 2.27929961 |
86 | Spontaneous hematomas (HP:0007420) | 2.27640487 |
87 | Periodontitis (HP:0000704) | 2.26152154 |
88 | Abnormality of methionine metabolism (HP:0010901) | 2.25168656 |
89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.24512046 |
90 | Agammaglobulinemia (HP:0004432) | 2.24473886 |
91 | Myositis (HP:0100614) | 2.23066412 |
92 | Mitral stenosis (HP:0001718) | 2.16999190 |
93 | Neuronal loss in central nervous system (HP:0002529) | 2.16411475 |
94 | Gastrointestinal infarctions (HP:0005244) | 2.15361637 |
95 | Premature loss of primary teeth (HP:0006323) | 2.15190969 |
96 | Mutism (HP:0002300) | 2.14015571 |
97 | Emphysema (HP:0002097) | 2.13592534 |
98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13494168 |
99 | Osteolytic defects of the hand bones (HP:0009699) | 2.13494168 |
100 | Recurrent pneumonia (HP:0006532) | 2.13477399 |
101 | Dysostosis multiplex (HP:0000943) | 2.13422075 |
102 | Hepatosplenomegaly (HP:0001433) | 2.12953313 |
103 | Steatorrhea (HP:0002570) | 2.12836110 |
104 | Thick nail (HP:0001805) | 2.11361180 |
105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10874106 |
106 | Inflammation of the large intestine (HP:0002037) | 2.10426454 |
107 | Thrombophlebitis (HP:0004418) | 2.10314272 |
108 | Hemorrhage of the eye (HP:0011885) | 2.09405175 |
109 | Ketosis (HP:0001946) | 2.06597192 |
110 | Respiratory distress (HP:0002098) | 2.05423247 |
111 | Chronic diarrhea (HP:0002028) | 2.03474472 |
112 | Hypergammaglobulinemia (HP:0010702) | 2.02957772 |
113 | Keratoconjunctivitis sicca (HP:0001097) | 2.02541940 |
114 | Abnormality of glycine metabolism (HP:0010895) | 2.02141628 |
115 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02141628 |
116 | Urticaria (HP:0001025) | 2.01903298 |
117 | Gastrointestinal inflammation (HP:0004386) | 2.01686578 |
118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00646544 |
119 | Vasculitis (HP:0002633) | 2.00433215 |
120 | Increased cerebral lipofuscin (HP:0011813) | 2.00216225 |
121 | Mucopolysacchariduria (HP:0008155) | 1.99432166 |
122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99432166 |
123 | Chronic otitis media (HP:0000389) | 1.97708973 |
124 | Delayed CNS myelination (HP:0002188) | 1.97267550 |
125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96342095 |
126 | Pulmonary embolism (HP:0002204) | 1.96117350 |
127 | Peritonitis (HP:0002586) | 1.95813916 |
128 | Increased IgM level (HP:0003496) | 1.95801740 |
129 | Prolonged neonatal jaundice (HP:0006579) | 1.95442990 |
130 | Stomatitis (HP:0010280) | 1.95228287 |
131 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95069797 |
132 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94189707 |
133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93970368 |
134 | Abnormality of iron homeostasis (HP:0011031) | 1.93887476 |
135 | Hyperglycinemia (HP:0002154) | 1.93643871 |
136 | Hypoglycemic coma (HP:0001325) | 1.93547905 |
137 | Cerebral inclusion bodies (HP:0100314) | 1.92604254 |
138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92199003 |
139 | Retrobulbar optic neuritis (HP:0100654) | 1.92081376 |
140 | Optic neuritis (HP:0100653) | 1.92081376 |
141 | Progressive neurologic deterioration (HP:0002344) | 1.91915564 |
142 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91164370 |
143 | Gangrene (HP:0100758) | 1.89964803 |
144 | Abnormality of the periventricular white matter (HP:0002518) | 1.89425307 |
145 | Petechiae (HP:0000967) | 1.88966006 |
146 | Menorrhagia (HP:0000132) | 1.87755386 |
147 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87628074 |
148 | Encephalitis (HP:0002383) | 1.87474174 |
149 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86221781 |
150 | Arthralgia (HP:0002829) | 1.85775890 |
151 | Lymphopenia (HP:0001888) | 1.85530325 |
152 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84756048 |
153 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84756048 |
154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84756048 |
155 | Asymmetric septal hypertrophy (HP:0001670) | 1.84059093 |
156 | Hypertensive crisis (HP:0100735) | 1.84058692 |
157 | Tetraparesis (HP:0002273) | 1.83626317 |
158 | T lymphocytopenia (HP:0005403) | 1.83369291 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.99366589 |
2 | TYK2 | 3.36062891 |
3 | ERN1 | 3.08942435 |
4 | TGFBR2 | 2.98763465 |
5 | BLK | 2.65821393 |
6 | PRPF4B | 2.63452565 |
7 | TBK1 | 2.61013081 |
8 | IRAK4 | 2.48717132 |
9 | IRAK3 | 2.48566415 |
10 | FGFR4 | 2.35810069 |
11 | IKBKE | 2.02309005 |
12 | JAK1 | 1.99793851 |
13 | IKBKB | 1.99207228 |
14 | NME2 | 1.97884566 |
15 | MAP4K1 | 1.96973474 |
16 | EPHB1 | 1.94444510 |
17 | TAOK3 | 1.92526322 |
18 | NEK9 | 1.92420576 |
19 | SIK1 | 1.70942430 |
20 | MAP3K3 | 1.67829689 |
21 | JAK3 | 1.67226845 |
22 | ZAP70 | 1.65720542 |
23 | CHUK | 1.63142837 |
24 | MST1R | 1.62127772 |
25 | MAP3K13 | 1.57835667 |
26 | KIT | 1.54399282 |
27 | RIPK4 | 1.51909980 |
28 | STK10 | 1.51505245 |
29 | CDC42BPA | 1.50610677 |
30 | BCKDK | 1.49905866 |
31 | CSF1R | 1.46637025 |
32 | CSK | 1.46299846 |
33 | PTK6 | 1.39580033 |
34 | MAP2K3 | 1.36377369 |
35 | LRRK2 | 1.32656212 |
36 | DDR2 | 1.32630985 |
37 | TRIB3 | 1.29529532 |
38 | JAK2 | 1.20009991 |
39 | TAOK2 | 1.19727514 |
40 | EPHA3 | 1.17404588 |
41 | SMG1 | 1.17165637 |
42 | FES | 1.14739981 |
43 | TIE1 | 1.13252692 |
44 | MAP3K1 | 1.10425863 |
45 | PDPK1 | 1.09254247 |
46 | BTK | 1.06888373 |
47 | EPHA2 | 1.04780895 |
48 | PIK3CG | 1.04271030 |
49 | GRK7 | 1.04042526 |
50 | TAOK1 | 1.02644162 |
51 | TEC | 0.99348202 |
52 | FGFR3 | 0.95795366 |
53 | PIM2 | 0.94398305 |
54 | SYK | 0.94382001 |
55 | ABL2 | 0.93821230 |
56 | FLT3 | 0.90828465 |
57 | FRK | 0.89510247 |
58 | MST4 | 0.88968531 |
59 | STK24 | 0.88581466 |
60 | PDK1 | 0.86952720 |
61 | RIPK1 | 0.86779627 |
62 | RPS6KA4 | 0.84465201 |
63 | PBK | 0.83930536 |
64 | PAK4 | 0.83588436 |
65 | CDK6 | 0.83250751 |
66 | CAMK1D | 0.80893673 |
67 | DAPK2 | 0.78220704 |
68 | KDR | 0.77204014 |
69 | MATK | 0.73851699 |
70 | LYN | 0.73564725 |
71 | TESK2 | 0.73560063 |
72 | KSR2 | 0.73283524 |
73 | MAP3K11 | 0.72755565 |
74 | MAPK15 | 0.72449309 |
75 | ARAF | 0.71490729 |
76 | GRK1 | 0.70461795 |
77 | ITK | 0.70450956 |
78 | PIM1 | 0.70064217 |
79 | HCK | 0.69224463 |
80 | BMX | 0.69153570 |
81 | PRKCQ | 0.68186363 |
82 | PRKAA2 | 0.67870318 |
83 | MAP3K2 | 0.67579660 |
84 | EGFR | 0.67262322 |
85 | MAPK12 | 0.65899851 |
86 | BMPR2 | 0.65134042 |
87 | SIK3 | 0.64672389 |
88 | INSRR | 0.61690386 |
89 | ABL1 | 0.61646715 |
90 | PRKCD | 0.60666929 |
91 | TNK2 | 0.60403877 |
92 | IRAK1 | 0.60171251 |
93 | MAPK11 | 0.59643262 |
94 | NUAK1 | 0.58886472 |
95 | GSK3A | 0.58460895 |
96 | FGFR2 | 0.56509839 |
97 | ERBB4 | 0.56264099 |
98 | MOS | 0.55760277 |
99 | ACVR1B | 0.55497394 |
100 | MAPK7 | 0.55092403 |
101 | MARK3 | 0.54093314 |
102 | MARK2 | 0.53895419 |
103 | PKN2 | 0.52856170 |
104 | GRK6 | 0.52497782 |
105 | SIK2 | 0.51343090 |
106 | EIF2AK2 | 0.51280847 |
107 | EPHB2 | 0.51089271 |
108 | STK3 | 0.50956578 |
109 | LCK | 0.50428347 |
110 | DYRK1B | 0.49637405 |
111 | IRAK2 | 0.48651632 |
112 | MET | 0.48618668 |
113 | EEF2K | 0.48449782 |
114 | RPS6KA2 | 0.48382017 |
115 | TRPM7 | 0.47965544 |
116 | CAMKK2 | 0.47014792 |
117 | FYN | 0.46510258 |
118 | ICK | 0.46472346 |
119 | IGF1R | 0.46067518 |
120 | PTK2 | 0.45809083 |
121 | PDGFRB | 0.45741170 |
122 | MAP3K8 | 0.45710491 |
123 | MAP2K6 | 0.44085276 |
124 | MAP2K2 | 0.43104925 |
125 | HIPK2 | 0.42839764 |
126 | MAPKAPK2 | 0.42407123 |
127 | MAPKAPK3 | 0.41485238 |
128 | YES1 | 0.41090448 |
129 | RPS6KL1 | 0.41024514 |
130 | RPS6KC1 | 0.41024514 |
131 | PDK2 | 0.39713920 |
132 | LATS1 | 0.38421736 |
133 | TXK | 0.38037200 |
134 | CAMKK1 | 0.37374286 |
135 | SGK3 | 0.36497324 |
136 | STK4 | 0.35045076 |
137 | FGR | 0.34739158 |
138 | MAPK4 | 0.34337932 |
139 | PRKCZ | 0.32663482 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.63485688 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.47288101 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.10147452 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06531396 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.03712009 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86847076 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.51750022 |
8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42498686 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40603174 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37234985 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34642894 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97261645 |
13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95627545 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93233248 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91925831 |
16 | Peroxisome_Homo sapiens_hsa04146 | 1.85338111 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84354724 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76740034 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72998780 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68445293 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66715732 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64551519 |
23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58025179 |
24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51023093 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45590392 |
26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42776233 |
27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39502592 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38950592 |
29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38476543 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.27943278 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23150780 |
32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22750153 |
33 | ABC transporters_Homo sapiens_hsa02010 | 1.22293103 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21963362 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19577879 |
36 | * Lysosome_Homo sapiens_hsa04142 | 1.19495364 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17273733 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.12002497 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11950074 |
40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09890236 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09381834 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08445666 |
43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06536579 |
44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06019580 |
45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05629022 |
46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04868801 |
47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03355079 |
48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02556003 |
49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01672296 |
50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99067447 |
51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95721590 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94960958 |
53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93672030 |
54 | Legionellosis_Homo sapiens_hsa05134 | 0.93112149 |
55 | Malaria_Homo sapiens_hsa05144 | 0.92970734 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 0.91714546 |
57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88975594 |
58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84021374 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83982985 |
60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82155480 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79719996 |
62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79338919 |
63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79205661 |
64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79025107 |
65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78781259 |
66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77357082 |
67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75306656 |
68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74462302 |
69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74305306 |
70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74176443 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74047266 |
72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74010705 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72067268 |
74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70077207 |
75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69976501 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.69253405 |
77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69178099 |
78 | Phagosome_Homo sapiens_hsa04145 | 0.68835265 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68364349 |
80 | Influenza A_Homo sapiens_hsa05164 | 0.67021052 |
81 | Measles_Homo sapiens_hsa05162 | 0.66780385 |
82 | Allograft rejection_Homo sapiens_hsa05330 | 0.66488740 |
83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65486744 |
84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65404779 |
85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65111814 |
86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65005805 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.64093121 |
88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63483374 |
89 | Shigellosis_Homo sapiens_hsa05131 | 0.63413038 |
90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62867556 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62721927 |
92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61151246 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60589540 |
94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59306803 |
95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58131728 |
96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57795706 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56302582 |
98 | Hepatitis C_Homo sapiens_hsa05160 | 0.55993225 |
99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55477789 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54109864 |
101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51905830 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51365532 |
103 | Bladder cancer_Homo sapiens_hsa05219 | 0.51181097 |
104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50476011 |
105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49195281 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49038855 |
107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48376593 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46990269 |
109 | * Apoptosis_Homo sapiens_hsa04210 | 0.46966121 |
110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46738711 |
111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46720003 |
112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46662236 |
113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46057884 |
114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45668606 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.45656748 |
116 | Mineral absorption_Homo sapiens_hsa04978 | 0.45440883 |
117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44430736 |
118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44071957 |
119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43685707 |
120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42497751 |
121 | Lysine degradation_Homo sapiens_hsa00310 | 0.42188036 |
122 | Platelet activation_Homo sapiens_hsa04611 | 0.40927596 |
123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40579712 |
124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40283033 |
125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38466804 |
126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38443549 |
127 | Asthma_Homo sapiens_hsa05310 | 0.38372015 |
128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38279327 |
129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38232218 |
130 | Salmonella infection_Homo sapiens_hsa05132 | 0.37840753 |
131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37560792 |
132 | Insulin resistance_Homo sapiens_hsa04931 | 0.36712780 |
133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36203283 |
134 | Endocytosis_Homo sapiens_hsa04144 | 0.35679826 |
135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35413869 |
136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35348503 |
137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32102475 |
138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30768954 |
139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30165568 |
140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29949248 |
141 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26392022 |
142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26209700 |
143 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25199281 |
144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24917927 |
145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22459722 |
146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20841826 |
147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20023731 |
148 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.17846481 |